COVID-19 Pneumonia in two Patients with Ankylosing Spondylitis Using Anti-TNF Agents
dc.contributor.author | Kurt, İdris | |
dc.contributor.author | Edis, Ebru Çakır | |
dc.contributor.author | Mert, Habibe Tülin Elmaslar | |
dc.date.accessioned | 2024-06-12T10:05:39Z | |
dc.date.available | 2024-06-12T10:05:39Z | |
dc.date.issued | 2021 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | The new type of coronavirus (SARS-CoV2) reported to have originated in China in December 2019 has spread rapidly all over the world and has become a global problem. COVID-19 is more common and more severe in people with such comorbidities as cardiovascular disease, hypertension and diabetes. There is a lack of consensus on whether rheumato- logical diseases and drugs used in their treatment increase the risk of developing COVID-19. There is also lack of data in literature regarding the develop- ment of COVID-19, especially in patients with Anky- losing Spondylitis. This case presentation relates to two patients with Ankylosing Spondylitis using anti- TNF agents who were affected by COVID-19. The younger of the two, who had no comorbidities, healed quickly with antiviral and supportive therapy, while the older patient, who had cardiovascular and chronic kidney comorbidities, experienced an aggres- sive disease course and did not survive. The course of COVID-19 infection and mortality is strongly con- nected with underlying comorbidities. Our focus here is on rheumatological diseases, their immunosup- pressive treatments and their impact on the course of the novel type Coronavirus infection, based on two cases of Ankylosing Spondylitis, in light of literature. | en_US |
dc.identifier.doi | 10.5505/respircase.2021.60565 | |
dc.identifier.endpage | 82 | en_US |
dc.identifier.issn | 2147-2475 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 78 | en_US |
dc.identifier.trdizinid | 504856 | en_US] |
dc.identifier.uri | https://doi.org/10.5505/respircase.2021.60565 | |
dc.identifier.uri | https://search.trdizin.gov.tr/yayin/detay/504856 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/13570 | |
dc.identifier.volume | 10 | en_US |
dc.indekslendigikaynak | TR-Dizin | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Respiratory Case Reports | en_US |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | COVID-19 Pneumonia in two Patients with Ankylosing Spondylitis Using Anti-TNF Agents | en_US |
dc.type | Article | en_US |